cayston
(aztreonam)Gilead Sciences, Inc.
Usage: CAYSTON® is indicated for improving respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. It is not established for use in patients under 7, those with FEV1 <25% or >75%, or those colonized with Burkholderia cepacia. It should only be used in confirmed Pseudomonas infections.